Safety of Risankizumab during Pregnancy in IBD

Noa Tsur, Ami Ben Ya’acov, Bella Ungar, Yulia Ron, Irit Avni-Biron, Hilla Reiss Mintz, Benjamin Koslowsky, Tali Mishael, Ariella Bar Gil Shitrit

Open source

DOI
10.1093/ibd/izaf305
Published
2025-12-22
Container
Inflammatory Bowel Diseases
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ibd/izaf305,
  title = {Safety of Risankizumab during Pregnancy in IBD},
  author = {Noa Tsur and Ami Ben Ya’acov and Bella Ungar and Yulia Ron and Irit Avni-Biron and Hilla Reiss Mintz and Benjamin Koslowsky and Tali Mishael and Ariella Bar Gil Shitrit},
  year = {2025},
  journal = {Inflammatory Bowel Diseases},
  doi = {10.1093/ibd/izaf305},
  url = {https://doi.org/10.1093/ibd/izaf305}
}

RIS

TY  - JOUR
TI  - Safety of Risankizumab during Pregnancy in IBD
AU  - Noa Tsur
AU  - Ami Ben Ya’acov
AU  - Bella Ungar
AU  - Yulia Ron
AU  - Irit Avni-Biron
AU  - Hilla Reiss Mintz
AU  - Benjamin Koslowsky
AU  - Tali Mishael
AU  - Ariella Bar Gil Shitrit
PY  - 2025
JO  - Inflammatory Bowel Diseases
DO  - 10.1093/ibd/izaf305
UR  - https://doi.org/10.1093/ibd/izaf305
ER  - 

APA

Tsur, N., Ya’acov, A. B., Ungar, B., Ron, Y., Avni-Biron, I., Mintz, H. R., Koslowsky, B., Mishael, T., & Shitrit, A. B. G. (2025). Safety of Risankizumab during Pregnancy in IBD. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izaf305

Source records